Pacific Biosciences of California Inc (NASDAQ:PACB) Risk Hits An Elevated LevelDate Published: 2018-03-13
Risk Alert: Before we dive into any analysis we simply note that Pacific Biosciences of California Inc (NASDAQ:PACB) risk is elevated. We'll detail it below -- but that's the lede -- the option market is starting to flash those neon lights that signal "risk is rising" with an IV30 of 95.91% versus the IV30 of the S&P 500 at 12.47%. The annual high for Pacific Biosciences of California Inc IV30 is 147.52%.
To skip ahead of this risk alert and see if buying or selling options has been a winner in Pacific Biosciences of California Inc, you can go here: Getting serious about option trading.
This is a proprietary risk rating and risk alert system that looks forward for the next month -- or really 30 days to be exact -- and that includes weekends. The system is based on multiple interactions of data points, many of which come directly from the option market for Pacific Biosciences of California Inc (NASDAQ:PACB) . The creator of this model is Capital Market Laboratories (CMLviz.com).
In the "Why This Matters" section at the end of this article on Pacific Biosciences of California Inc we're going to take a step back and show in great specificity that there is actually a lot less "luck" in successful option trading than many people know. The whole concept of an "option trading expert" is vastly over complicated and we'll talk about how superior returns are earned.
But first, let's turn back to PACB and the company's risk rating:
We also take a peek at the implied vol for the Health Care ETF (XLV), our broad based proxy for PACB.
|S&P 500 IV30||12.47%|
|Nasdaq 100 IV30||15.97%|
|PACB HV 30||56.65%|
|PACB Current IV30||95.91%|
|52 Week Low IV30||52.58%|
|52 Week High IV30||147.52%|
The implied price swing risk as reflected by the option market has hit an elevated level relative to the company's past. The option market reflects a 95% confidence interval stock price range of ($2.20, $3.40) within the next 30 calendar days.
PACB OPTION MARKET IMPLIED PRICE SWING RISK
The IV30® is the implied price swing risk reflected by the option market in the stock price for the next 30 calendar days -- it's forward looking. Pacific Biosciences of California Inc shows an IV30 of 95.9%, which is an elevated level for the company relative to its past.
The option market for PACB has shown an IV30 annual low of 52.6% and an annual high of 147.5%, meaning that PACB is at the 46% percentile right now. Here's a table of the data before we dig into the implied price swing risk rating further.
The implied stock swing risk from the option market has created a range which is tighter in the next 30 calendar days for Pacific Biosciences of California Inc (NASDAQ:PACB) than it has been on average for the last year on average. But, even though the IV30 percentile is below 50, other critical volatility measures that we discuss below point to substantially elevated swing price risk.
We have an unusual situation now where the IV30 is depressed relative to the past, but even with that risk pricing, the option market reflects the likelihood of a greater stock movement in the next 30-days than the stock has realized in the last 30-days. Let's turn to a chart to see what's going on.
Pacific Biosciences of California Inc Risk Rating
The PACB risk rating is at 4.5, where the rating goes from one (the lowest risk) to five (the highest risk). The driving factors for the 4.5 rating are:
↪ The IV30 is below the annual average.
↪ The IV30 is above 90%, which is very elevated.
↪ The HV30 is below the annual average.
↪ The IV30 is above the HV30.
↪ The stock has moved just +2.2% over the last 3-months which does indicate some depressed risk.